FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

William Chambers

Research Profile

Anatomy

Living Beings

Chemicals & Drugs

Physiology

Cytotoxicity, Immunologic

Procedures

Flow Cytometry

Disorders

Co-author Network

Publications

TOP 3
Shivendra V Singh; Renaud Warin; Dong Xiao; Anna A Powolny; Silvia D Stan; Julie A Arlotti; Yan Zeng; Eun-Ryeong Hahm; Stanley W Marynowski; Ajay Bommareddy; Dhimant Desai; Shantu Amin; Robert A Parise; Jan H Beumer; William Chambers
Sulforaphane inhibits prostate carcinogenesis and pulmonary metastasis in TRAMP mice in association with increased cytotoxicity of natural killer cells.
Melanie S Flint; Andrew Baum; William Chambers; Frank J Jenkins
Induction of DNA damage, alteration of DNA repair and transcriptional activation by stress hormones.
Tianbing Yang; Melanie S Flint; Katie M Webb; William Chambers
CD161B:ClrB interactions mediate activation of enhanced lysis of tumor target cells following NK cell:DC co-culture.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of William Chambers (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2009: Shivendra V Singh; Renaud Warin; Dong Xiao; Anna A Powolny; Silvia D Stan; Julie A Arlotti; Yan Zeng; Eun-Ryeong Hahm; Stanley W Marynowski; Ajay Bommareddy; Dhimant Desai; Shantu Amin; Robert A Parise; Jan H Beumer; William Chambers
Sulforaphane inhibits prostate carcinogenesis and pulmonary metastasis in TRAMP mice in association with increased cytotoxicity of natural killer cells.
Cancer research 2009;69(5):2117-25.
2007: Melanie S Flint; Andrew Baum; William Chambers; Frank J Jenkins
Induction of DNA damage, alteration of DNA repair and transcriptional activation by stress hormones.
Psychoneuroendocrinology 2007;32(5):470-9.
2006: Tianbing Yang; Melanie S Flint; Katie M Webb; William Chambers
CD161B:ClrB interactions mediate activation of enhanced lysis of tumor target cells following NK cell:DC co-culture.
Immunologic research 2006;36(1-3):43-50.
2005: Melanie S Flint; Judith E Carroll; Frank J Jenkins; William Chambers; Melissa L Han; Andrew Baum
Genomic profiling of restraint stress-induced alterations in mouse T lymphocytes.
Journal of neuroimmunology 2005;167(1-2):34-44.
2005: Timothy F Witham; Hideho Okada; Wendy Fellows; Ronald L Hamilton; John C Flickinger; William Chambers; Ian F Pollack; simon simon watkins; Douglas Kondziolka
The characterization of tumor apoptosis after experimental radiosurgery.
Stereotactic and functional neurosurgery 2005;83(1):17-24.
2004: Shen Li; Jun Xu; Valeria P Makarenkova; Tjendimin Tjandrawan; Jukka Vakkila; Torsten E Reichert; William Gooding; Carl F Lagenaur; Cristian L Achim; William Chambers; Ronald Herberman; Theresa L Whiteside; Nikola L Vujanovic
A novel epitope of N-CAM defines precursors of human adherent NK cells.
Journal of leukocyte biology 2004;76(6):1187-99.
2004: Hideho Okada; Takahiko Tsugawa; Hidemitsu Sato; Naruo Kuwashima; Andrea Gambotto; Kaori Okada; Jill E Dusak; Wendy Fellows-Mayle; Glenn D Papworth; simon simon watkins; William Chambers; Douglas M Potter; Walter J Storkus; Ian F Pollack
Delivery of interferon-alpha transfected dendritic cells into central nervous system tumors enhances the antitumor efficacy of peripheral peptide-based vaccines.
Cancer research 2004;64(16):5830-8.
2003: Timothy F Witham; Lorissa Villa; Tianbing Yang; Ian F Pollack; Hideho Okada; Paul D Robbins; William Chambers
Expression of a soluble transforming growth factor-beta (TGFbeta) receptor reduces tumorigenicity by regulating natural killer (NK) cell activity against 9L gliosarcoma in vivo.
Journal of neuro-oncology 2003;64(1-2):63-9.
2002: Anna L Marsland; Brent N Henderson; William Chambers; Andrew Baum
Stability of individual differences in cellular immune responses to two different laboratory tasks.
Psychophysiology 2002;39(6):865-8.
2002: Fumiyoshi Okano; Walter J Storkus; William Chambers; Ian F Pollack; Hideho Okada
Identification of a novel HLA-A*0201-restricted, cytotoxic T lymphocyte epitope in a human glioma-associated antigen, interleukin 13 receptor alpha2 chain.
Clinical cancer research : an official journal of the American Association for Cancer Research 2002;8(9):2851-5.
2002: Cynthia S Brissette-Storkus; J C Kettel; T F Whitham; KM Giezeman-Smits; L A Villa; Douglas M Potter; William Chambers
Flt-3 ligand (FL) drives differentiation of rat bone marrow-derived dendritic cells expressing OX62 and/or CD161 (NKR-P1).
Journal of leukocyte biology 2002;71(6):941-9.
2002: Timothy F Witham; Melanie L Erff; Hideho Okada; William Chambers; Ian F Pollack
7-Hydroxystaurosporine-induced apoptosis in 9L glioma cells provides an effective antigen source for dendritic cells and yields a potent vaccine strategy in an intracranial glioma model.
Neurosurgery 2002;50(6):1327-34; discussion 1334-5.
2002: Tianbing Yang; Timothy F Witham; Lorissa Villa; Melanie L Erff; Jason Attanucci; simon simon watkins; Douglas Kondziolka; Hideho Okada; Ian F Pollack; William Chambers
Glioma-associated hyaluronan induces apoptosis in dendritic cells via inducible nitric oxide synthase: implications for the use of dendritic cells for therapy of gliomas.
Cancer research 2002;62(9):2583-91.
2001: N Nakahara; Hideho Okada; Timothy F Witham; Jason Attanucci; Wendy Fellows; William Chambers; A Niranjan; Douglas Kondziolka; Ian F Pollack
Combination of stereotactic radiosurgery and cytokine gene-transduced tumor cell vaccination: a new strategy against metastatic brain tumors.
Journal of neurosurgery 2001;95(6):984-9.
2001: Hideho Okada; Lorissa Villa; Jason Attanucci; Melanie L Erff; Wendy Fellows; Michael T Lotze; Ian F Pollack; William Chambers
Cytokine gene therapy of gliomas: effective induction of therapeutic immunity to intracranial tumors by peripheral immunization with interleukin-4 transduced glioma cells.
Gene therapy 2001;8(15):1157-66.
2001: Hideho Okada; Ian F Pollack; Frank S Lieberman; L Dade Lunsford; Douglas Kondziolka; David Schiff; Jason Attanucci; Howard D Edington; William Chambers; Pawel Kalinski; D Kinzler; Theresa L Whiteside; Elaine Elder; D Potter
Gene therapy of malignant gliomas: a pilot study of vaccination with irradiated autologous glioma and dendritic cells admixed with IL-4 transduced fibroblasts to elicit an immune response.
Human gene therapy 2001;12(5):575-95.
2001: Hideho Okada; Jason Attanucci; KM Giezeman-Smits; Cynthia S Brissette-Storkus; Wendy Fellows; Andrea Gambotto; L F Pollack; Kay L Pogue-Geile; Michael T Lotze; ME Bozik; William Chambers
Immunization with an antigen identified by cytokine tumor vaccine-assisted SEREX (CAS) suppressed growth of the rat 9L glioma in vivo.
Cancer research 2001;61(6):2625-31.
2000: Ian F Pollack; Hideho Okada; William Chambers
Exploitation of immune mechanisms in the treatment of central nervous system cancer.
Seminars in pediatric neurology 2000;7(2):131-43.
2000: KM Giezeman-Smits; Hideho Okada; Cynthia S Brissette-Storkus; L A Villa; Jason Attanucci; Michael T Lotze; Ian F Pollack; ME Bozik; William Chambers
Cytokine gene therapy of gliomas: induction of reactive CD4+ T cells by interleukin-4-transfected 9L gliosarcoma is essential for protective immunity.
Cancer research 2000;60(9):2449-57.
2000: Hideho Okada; Jason Attanucci; Hideaki Tahara; Ian F Pollack; ME Bozik; William Chambers; Michael T Lotze
Characterization and transduction of a retroviral vector encoding human interleukin-4 and herpes simplex virus-thymidine kinase for glioma tumor vaccine therapy.
Cancer gene therapy 2000;7(3):486-94.
2000: Hideho Okada; Ian F Pollack; Michael T Lotze; L Dade Lunsford; Douglas Kondziolka; Frank S Lieberman; David Schiff; Jason Attanucci; Howard D Edington; William Chambers; Paul Robbins; Joseph Baar; D Kinzler; Theresa L Whiteside; Elaine Elder
Gene therapy of malignant gliomas: a phase I study of IL-4-HSV-TK gene-modified autologous tumor to elicit an immune response.
Human gene therapy 2000;11(4):637-53.
2000: William Chambers; S M Watkins; Per H Basse
Methods for in vivo analyses of natural killer (NK) cells.
Methods in molecular biology (Clifton, N.J.) 2000;121():95-114.
1999: C J Rogers; Cynthia S Brissette-Storkus; William Chambers; Judy L Cameron
Acute stress impairs NK cell adhesion and cytotoxicity through CD2, but not LFA-1.
Journal of neuroimmunology 1999;99(2):230-41.
1999: Diana Metes; M Manciulea; D Pretrusca; Hannah Rabinowich; Linda K Ernst; iulia popescu; Ana Calugaru; A Sulica; William Chambers; Ronald Herberman; Penelope A Morel
Ligand binding specificities and signal transduction pathways of Fc gamma receptor IIc isoforms: the CD32 isoforms expressed by human NK cells.
European journal of immunology 1999;29(9):2842-52.
1999: M Neipp; James S Gammie; Beate G Exner; Sen Li; William Chambers; Si Pham; Suzanne Ildstad
A partial conditioning approach to achieve mixed chimerism in the rat: depletion of host natural killer cells significantly reduces the amount of total body irradiation required for engraftment.
Transplantation 1999;68(3):369-78.
1999: N Quan; Zhaobin Zhang; Melissa K Demetrikopoulos; Richard P Kitson; William Chambers; Ronald H Goldfarb; Jay M Weiss
Evidence for involvement of B lymphocytes in the surveillance of lung metastasis in the rat.
Cancer research 1999;59(5):1080-9.
1999: Hideho Okada; KM Giezeman-Smits; Hideaki Tahara; Jason Attanucci; Wendy Fellows; Michael T Lotze; William Chambers; ME Bozik
Effective cytokine gene therapy against an intracranial glioma using a retrovirally transduced IL-4 plus HSVtk tumor vaccine.
Gene therapy 1999;6(2):219-26.
1999: Muriel A Hagenaars; N Geeske Ensink; Liesbeth E Jonges; William Chambers; Alexander M M Eggermont; Cornelis J H van de Velde; Gert Jan Fleuren; Peter Kuppen
The development of a bi-specific anti-CD161A x anti-tumor antibody for rat NK cell targeting.
Immunobiology 1999;200(1):31-48.
1998: Hideho Okada; Hideaki Tahara; Michael R Shurin; Jason Attanucci; KM Giezeman-Smits; Wendy Fellows; Michael T Lotze; William Chambers; ME Bozik
Bone marrow-derived dendritic cells pulsed with a tumor-specific peptide elicit effective anti-tumor immunity against intracranial neoplasms.
International journal of cancer. Journal international du cancer 1998;78(2):196-201.
1998: C J Rogers; Cynthia S Brissette-Storkus; L A Hayes; Judy L Cameron; William Chambers
Selective reduction in CD2 expression on CD2bright/CD8+ lymphocytes from cynomolgus monkeys (Macaca fascicularis) in response to acute stress.
Journal of neuroimmunology 1998;86(1):63-73.
1998: Diana Metes; Linda K Ernst; William Chambers; A Sulica; Ronald Herberman; Penelope A Morel
Expression of functional CD32 molecules on human NK cells is determined by an allelic polymorphism of the FcgammaRIIC gene.
Blood 1998;91(7):2369-80.
1998: W A Gourlay; William Chambers; Anthony P Monaco; Takashi Maki
Importance of natural killer cells in the rejection of hamster skin xenografts.
Transplantation 1998;65(5):727-34.
1998: KM Giezeman-Smits; Liesbeth E Jonges; William Chambers; C S Brisette-Storkus; Ronald L P van Vlierberghe; Jaap van Eendenburg; Alexander M M Eggermont; Gert Jan Fleuren; Peter Kuppen
Novel monoclonal antibodies against membrane structures that are preferentially expressed on IL-2-activated rat NK cells.
Journal of leukocyte biology 1998;63(2):209-15.
1997: Fred Fändrich; X Zhu; Bettina Dresske; A Papachrysanthou; Beate G Exner; William Chambers
Impact of RT1.C-encoded MHC antigens on host-versus-graft and graft versus-host reactions in a model of small bowel transplantation in the rat.
Transplantation proceedings 1997;29(3):1730-1.
1997: Bruce S McEwen; C A Biron; KW Brunson; Karen Bulloch; William Chambers; Firdaus S Dhabhar; R H Goldfarb; Richard P Kitson; Andrew H Miller; Robert L Spencer; J M Weiss
The role of adrenocorticoids as modulators of immune function in health and disease: neural, endocrine and immune interactions.
Brain research. Brain research reviews 1997;23(1-2):79-133.
1997: J R Piccotti; Cynthia S Brissette-Storkus; William Chambers; J D Bricker
Suppression of splenic T lymphocyte proliferation by acute cocaine administration.
Life sciences 1997;61(10):967-76.
1996: Fred Fändrich; J Schröder; T Jahnke; Bettina Dresske; William Chambers; Nicholas Zavazava
Modulation of graft-vs-host-related disease by host-specific natural killer cell activity following semiallogeneic small bowel transplantation in the rat.
Transplantation proceedings 1996;28(6):3267-8.
1996: Fred Fändrich; Beate G Exner; A Papachrysanthou; T Jahnke; William Chambers; Nicholas Zavazava
Impact of natural killer cells in mediating graft-versus-host disease following small bowel transplantation in a rat model.
Transplantation proceedings 1996;28(5):2465-6.
1996: William Chambers; ME Bozik; S C Brissette-Storkus; Per H Basse; ES Redgate; S Watkins; SS Boggs
NKR-P1+ cells localize selectively in Rat 9L gliosarcomas but have reduced cytolytic function.
Cancer research 1996;56(15):3516-25.
1996: PM Appasamy; T W Kenniston; Cynthia S Brissette-Storkus; William Chambers
NKR-P1dim/TCR alpha beta + T cells and natural killer cells share expression of NKR-P1A and NKR-P1D.
Natural immunity 1996;15(5):259-68.
1996: Fred Fändrich; Beate G Exner; A Papachrysanthou; X Zhu; T Jahnke; William Chambers; Nicholas Zavazava
In vivo depletion of NKR-P1 positive cells in the recipient prior to small bowel transplantation enhances graft-versus-host disease (GvHD) in the rat.
Transplant international : official journal of the European Society for Organ Transplantation 1996;9 Suppl 1():S275-80.
1996: D Pinard; N O Olsson; William Chambers; F Martin
High expression of NKR-P1 is not an absolute requirement for natural killer activity in BDIX rats.
Cancer immunology, immunotherapy : CII 1996;42(1):15-23.
1995: William Chambers; Cynthia S Brissette-Storkus
Hanging in the balance: natural killer cell recognition of target cells.
Chemistry & biology 1995;2(7):429-35.
1995: Nikola L Vujanovic; Lorenzo Polimeno; A Azzarone; Antonio Francavilla; William Chambers; Thomas E Starzl; Ronald Herberman; Theresa L Whiteside
Changes of liver-resident NK cells during liver regeneration in rats.
Journal of immunology (Baltimore, Md. : 1950) 1995;154(12):6324-38.
1995: Fred Fändrich; Beate G Exner; A Papachrysanthou; William Chambers; Nicholas Zavazava
Paradoxical rejection pattern of donor small bowel in young F1-rats in a graft-versus-host strain combination.
Transplantation proceedings 1995;27(2):1620-1.
1995: William Chambers; Andrew A Amoscato; M Susan Smith; T W Kenniston; Ronald Herberman; PM Appasamy
Prolactin receptor expression by rat NK cells.
Natural immunity 1995;14(3):145-56.
1995: A Sulica; William Chambers; M Manciulea; Diana Metes; Seth J Corey; Hannah Rabinowich; Theresa L Whiteside; Ronald Herberman
Divergent signal transduction pathways and effects on natural killer cell functions induced by interaction of Fc receptors with physiologic ligands or antireceptor antibodies.
Natural immunity 1995;14(3):123-33.
1995: Cynthia S Brissette-Storkus; PM Appasamy; L A Hayes; C L Kaufman; Suzanne Ildstad; William Chambers
Characterization and comparison of the lytic function of NKR-P1+ and NKR-P1-rat natural killer cell clones established from NKR-P1bright/TCR alpha beta-cell lines.
Natural immunity 1995;14(2):98-113.
1995: S L Giardina; S K Anderson; T J Sayers; William Chambers; G A Palumbo; Howard A Young; John R Ortaldo
Selective loss of NK cytotoxicity in antisense NK-TR1 rat LGL cell lines. Abrogation of antibody-independent tumor and virus-infected target cell killing.
Journal of immunology (Baltimore, Md. : 1950) 1995;154(1):80-7.
1994: Diana Metes; C Galatiuc; I Moldovan; Penelope A Morel; William Chambers; Albert B DeLeo; Hannah Rabinowich; R Schall; Theresa L Whiteside; A Sulica
Expression and function of Fc gamma RII on human natural killer cells.
Natural immunity 1994;13(6):289-300.
1994: Karel Bezouska; G Vlahas; O Horváth; G Jinochová; Anna Fiserová; R Giorda; William Chambers; Ten Feizi; Miloslav Pospísil
Rat natural killer cell antigen, NKR-P1, related to C-type animal lectins is a carbohydrate-binding protein.
The Journal of biological chemistry 1994;269(24):16945-52.
1994: Andrew A Amoscato; R R Spiess; A M Brumfield; Ronald Herberman; William Chambers
Surface aminopeptidase activity of rat natural killer cells. I. Biochemical and biological properties.
Biochimica et biophysica acta 1994;1221(3):221-32.
1994: Cynthia S Brissette-Storkus; C L Kaufman; L Pasewicz; H M Worsey; R Lakomy; Suzanne Ildstad; William Chambers
Characterization and function of the NKR-P1dim/T cell receptor-alpha beta+ subset of rat T cells.
Journal of immunology (Baltimore, Md. : 1950) 1994;152(2):388-96.
1993: PM Appasamy; T W Kenniston; Y Weng; E C Holt; J Kost; William Chambers
Interleukin 7-induced expression of specific T cell receptor gamma variable region genes in murine fetal liver cultures.
The Journal of experimental medicine 1993;178(6):2201-6.
1993: C L Kaufman; William Chambers; Suzanne Ildstad
Coexpression of NKR-P1 and alpha beta-TCR on lymphoid cells in fully xenogeneic (rat-->mouse) chimeras and syngeneically reconstituted (A-->A) rats.
Journal of immunology (Baltimore, Md. : 1950) 1993;151(11):6002-11.
1993: Andrew A Amoscato; R R Spiess; S B Sansoni; Ronald Herberman; William Chambers
Degradation of enkephalins by rat lymphocyte and purified rat natural killer cell surface aminopeptidases.
Brain, behavior, and immunity 1993;7(2):176-87.
1993: William Chambers; Thomas Adamkiewicz; J P Houchins
Type II integral membrane proteins with characteristics of C-type animal lectins expressed by natural killer (NK) cells.
Glycobiology 1993;3(1):9-14.
1992: C L Kaufman; William Chambers; S M Wren; A Y Abou el-Ezz; Suzanne Ildstad
Preferential development of NKR-P1-expressing cells in the spleen versus thymus and bone marrow of fully xenogeneic (rat-->mouse) chimeras.
Transplantation proceedings 1992;24(6):2887-8.
1992: William Chambers; A M Brumfield; K Hanley-Yanez; R Lakomy; Ronald Herberman; D C McCaslin; M W Olszowy; J P McCoy
Functional heterogeneity between NKR-P1bright/Lycopersicon esculentum lectin (L.E.)bright and NKR-P1bright/L.E.dim subpopulations of rat natural killer cells.
Journal of immunology (Baltimore, Md. : 1950) 1992;148(11):3658-65.
1991: J P McCoy; William Chambers
Carbohydrates in the functions of natural killer cells.
Glycobiology 1991;1(4):321-8.
1991: Andrew A Amoscato; A M Brumfield; S B Sansoni; Ronald Herberman; William Chambers
Natural killer cell cytolytic granule-associated enzymes. I. Purification, characterization, and analysis of function of an enzyme with sulfatase activity.
Journal of immunology (Baltimore, Md. : 1950) 1991;147(3):950-8.
1991: J P McCoy; William Chambers; R Lakomy; J A Campbell; C C Stewart
Sorting minor subpopulations of cells: use of fluorescence as the triggering signal.
Cytometry 1991;12(3):268-74.
1990: R Giorda; William A Rudert; C Vavassori; William Chambers; J C Hiserodt; Massimo Trucco
NKR-P1, a signal transduction molecule on natural killer cells.
Science (New York, N.Y.) 1990;249(4974):1298-300.
1990: J P McCoy; K Hanley-Yanez; A Brumfield; Ronald Herberman; William Chambers
Alterations in cell-surface carbohydrates of rat large granular lymphocytes associated with interleukin-2 activation.
Cellular immunology 1990;127(2):275-83.
1990: R Giorda; William Chambers; C A Dahl; Massimo Trucco
Isolation and characterization of a cDNA that encodes the core protein of the cytolytic granule proteoglycan in rat natural killer cells.
Natural immunity and cell growth regulation 1990;9(2):91-102.
1990: William Chambers; T N Oeltmann
Alpha-mannosidase treatment of NK cells does not inhibit NK cell lytic function.
Lymphokine research 1990;9(2):239-45.
1989: William Chambers; Nikola L Vujanovic; Albert B DeLeo; M W Olszowy; Ronald Herberman; J C Hiserodt
Monoclonal antibody to a triggering structure expressed on rat natural killer cells and adherent lymphokine-activated killer cells.
The Journal of experimental medicine 1989;169(4):1373-89.
1988: J C Hiserodt; William Chambers; Ronald Herberman
Lymphokine-activated killer cells: analysis of their anti-tumour efficacy in vitro and in vivo.
Annales de l'Institut Pasteur. Immunology 1988;139(4):466-78.
1988: W Edward Robinson; W M Mitchell; William Chambers; S S Schuffman; D C Montefiori; T N Oeltmann
Natural killer cell infection and inactivation in vitro by the human immunodeficiency virus.
Human pathology 1988;19(5):535-40.
1988: J C Hiserodt; William Chambers
Role of soluble cytotoxic factors in lymphokine-activated killer cell (LAK)-mediated cytotoxicity.
Annals of the New York Academy of Sciences 1988;532():395-404.
1987: J C Hiserodt; William Chambers
Is there evidence for transfer of materials from the killer cell to the target requisite for target cell lysis?
Annales de l'Institut Pasteur. Immunology 1987;138(2):324-7.
1986: William Chambers; T N Oeltmann
The effects of hexose 6-O-sulfate esters on human natural killer cell lytic function.
Journal of immunology (Baltimore, Md. : 1950) 1986;137(5):1469-74.
1985: William Chambers; S M Washburn; M Campos; P H Klesius
Isolation of bovine eosinophils by density gradient centrifugation.
American journal of veterinary research 1985;46(1):154-6.
1984: P H Klesius; William Chambers; R D Schultz
Effect of bacterial lipopolysaccharide on bovine polymorphonuclear neutrophil migration in vitro.
Veterinary immunology and immunopathology 1984;7(3-4):239-44.
1983: William Chambers; J R Taylor; P H Klesius
Isolation of bovine polymorphonuclear leukocytes by density gradient centrifugation.
Veterinary immunology and immunopathology 1983;5(2):197-202.
1983: William Chambers; P H Klesius
Direct bovine leukocyte migration inhibition assay: standardization and comparison with skin testing.
Veterinary immunology and immunopathology 1983;5(1):85-95.
1979: P H Klesius; A L Elston; William Chambers; H H Fudenberg
Resistance to coccidiosis (Eimeria ferrisi) in C57BL/6 mice: effects of immunization and transfer factor.
Clinical immunology and immunopathology 1979;12(2):143-9.